quinoxalines has been researched along with Brain Embolism and Thrombosis in 5 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 5 (100.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 0 (0.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Boysen, G; Overgaard, K; Pedersen, H; Sereghy, T | 1 |
Boysen, G; Meden, P; Overgaard, K; Sereghy, T | 1 |
Cai, H; Fujishima, M; Ibayashi, S; Nakane, H; Uchimura, H; Yao, H | 1 |
Umemura, K | 1 |
Ikeda, Y; Kondo, K; Takamatsu, H; Umemura, K | 1 |
1 review(s) available for quinoxalines and Brain Embolism and Thrombosis
Article | Year |
---|---|
[A novel photochemical model of the middle cerebral artery for thrombosis research and evaluation of anti-thrombotic agents].
Topics: Animals; Disease Models, Animal; Drug Evaluation; Fibrinolytic Agents; Fluorescent Dyes; Glutamic Acid; Intracranial Embolism and Thrombosis; Light; Magnetic Resonance Imaging; Nicotinic Acids; Photochemistry; Quinoxalines; Receptors, AMPA; Receptors, N-Methyl-D-Aspartate; Rose Bengal | 1997 |
4 other study(ies) available for quinoxalines and Brain Embolism and Thrombosis
Article | Year |
---|---|
Neuroprotection with NBQX and thrombolysis with rt-PA in rat embolic stroke.
Topics: Animals; Brain Edema; Cerebral Infarction; Cerebrovascular Circulation; Fibrinolysis; Intracranial Embolism and Thrombosis; Male; Paralysis; Quinoxalines; Rats; Rats, Sprague-Dawley; Recombinant Proteins; Thrombolytic Therapy; Tissue Plasminogen Activator; Weight Loss | 1993 |
Enhancing the efficacy of thrombolysis by AMPA receptor blockade with NBQX in a rat embolic stroke model.
Topics: Animals; Blood Pressure; Cerebral Angiography; Cerebral Infarction; Cerebrovascular Circulation; Cerebrovascular Disorders; Fibrinolytic Agents; Intracranial Embolism and Thrombosis; Male; Plasminogen Activators; Quinoxalines; Rats; Rats, Sprague-Dawley; Receptors, AMPA | 1993 |
AMPA receptor antagonist, YM90K, reduces infarct volume in thrombotic distal middle cerebral artery occlusion in spontaneously hypertensive rats.
Topics: Animals; Arterial Occlusive Diseases; Cerebral Infarction; Drug Evaluation, Preclinical; Excitatory Amino Acid Antagonists; Hypertension; Intracranial Embolism and Thrombosis; Male; Neuroprotective Agents; Quinoxalines; Rats; Rats, Inbred SHR; Receptors, AMPA | 1997 |
Neuroprotective effects depend on the model of focal ischemia following middle cerebral artery occlusion.
Topics: Animals; Brain Edema; Brain Ischemia; Disease Models, Animal; Dizocilpine Maleate; Electrocoagulation; Immunosuppressive Agents; Injections, Intraperitoneal; Injections, Intravenous; Intracranial Embolism and Thrombosis; Male; Neuroprotective Agents; Quinoxalines; Rats; Rats, Sprague-Dawley; Tacrolimus | 1998 |